批准日期，申请提交历史，通知信，药品说明书，审评文件等信息
| 提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级；罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
|---|
| 2020/07/10 |
ORIG-1（原始申请） |
Approval |
|
STANDARD
|
|
|
与本品相关的专利信息（来自FDA橙皮书Orange Book）
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
|---|
| 无 |
与本品治疗等效的药品
活性成分:MAGNESIUM SULFATE 剂型/给药途径:INJECTABLE;INJECTION 规格:2GM/50ML (40MG/ML) 治疗等效代码:AP
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
|---|
| 020309 |
003 |
NDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
2GM/50ML (40MG/ML) |
Prescription |
Yes |
No |
AP |
2007/01/26
|
HOSPIRA |
| 206485 |
003 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
2GM/50ML (40MG/ML) |
Prescription |
No |
No |
AP |
2016/03/15
|
FRESENIUS KABI USA |
| 207350 |
001 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
2GM/50ML (40MG/ML) |
Prescription |
No |
No |
AP |
2017/12/06
|
HQ SPCLT PHARMA |
| 209911 |
001 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
2GM/50ML (40MG/ML) |
Prescription |
No |
No |
AP |
2018/09/14
|
MYLAN LABS LTD |
| 211966 |
001 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
2GM/50ML (40MG/ML) |
Prescription |
No |
No |
AP |
2020/06/01
|
BAXTER HLTHCARE CORP |
| 213917 |
001 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
2GM/50ML (40MG/ML) |
Prescription |
No |
No |
AP |
2020/07/10
|
GLAND PHARMA LTD |
| 207967 |
001 |
ANDA |
MAGNESIUM SULFATE |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
2GM/50ML (40MG/ML) |
Prescription |
No |
No |
AP |
2021/04/26
|
B BRAUN MEDICAL INC |
| 209642 |
001 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
2GM/50ML (40MG/ML) |
Prescription |
No |
No |
AP |
2021/11/08
|
MILLA PHARMS |
| 216597 |
001 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
2GM/50ML (40MG/ML) |
Prescription |
No |
No |
AP |
2023/02/15
|
AMNEAL |
活性成分:MAGNESIUM SULFATE 剂型/给药途径:INJECTABLE;INJECTION 规格:4GM/100ML (40MG/ML) 治疗等效代码:AP
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
|---|
| 020309 |
001 |
NDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
4GM/100ML (40MG/ML) |
Prescription |
Yes |
Yes |
AP |
1994/06/24
|
HOSPIRA |
| 206485 |
001 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
4GM/100ML (40MG/ML) |
Prescription |
No |
No |
AP |
2016/03/15
|
FRESENIUS KABI USA |
| 207350 |
002 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
4GM/100ML (40MG/ML) |
Prescription |
No |
No |
AP |
2017/12/06
|
HQ SPCLT PHARMA |
| 209911 |
002 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
4GM/100ML (40MG/ML) |
Prescription |
No |
No |
AP |
2018/09/14
|
MYLAN LABS LTD |
| 211966 |
003 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
4GM/100ML (40MG/ML) |
Prescription |
No |
No |
AP |
2020/06/01
|
BAXTER HLTHCARE CORP |
| 213917 |
002 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
4GM/100ML (40MG/ML) |
Prescription |
No |
No |
AP |
2020/07/10
|
GLAND PHARMA LTD |
| 207967 |
002 |
ANDA |
MAGNESIUM SULFATE |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
4GM/100ML (40MG/ML) |
Prescription |
No |
No |
AP |
2021/04/26
|
B BRAUN MEDICAL INC |
| 209642 |
002 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
4GM/100ML (40MG/ML) |
Prescription |
No |
No |
AP |
2021/11/08
|
MILLA PHARMS |
| 216597 |
002 |
ANDA |
MAGNESIUM SULFATE IN PLASTIC CONTAINER |
MAGNESIUM SULFATE |
INJECTABLE;INJECTION |
4GM/100ML (40MG/ML) |
Prescription |
No |
No |
AP |
2023/02/15
|
AMNEAL |